Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02903914
Title Arginase Inhibitor CB-1158 in Patients With Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Calithera Biosciences, Inc
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | ITA | ESP

Facility Status City State Zip Country Details
University of South Alabama Mobile Alabama 36604 United States Details
Honor Health/Pinnacle Oncology Hematology Scottsdale Arizona 85258 United States Details
University of Arizona Tucson Arizona 85719 United States Details
Georgetown Washington District of Columbia 20007 United States Details
Johns Hopkins Baltimore Maryland 21287 United States Details
BIDMC Boston Massachusetts 02215 United States Details
DFCI Boston Massachusetts 02215 United States Details
Henry Ford Detroit Michigan 48202 United States Details
Sarah Cannon Research Institute at Tennessee Oncology Nashville Tennessee 37203 United States Details
Vanderbilt Nashville Tennessee 37232 United States Details
MD Anderson Houston Texas 77230-1402 United States Details
MD Anderson Houston Texas 77230 United States Details
START San Antonio Texas 78229 United States Details
Ospedale San Raffaele Milan 20132 Italy Details
Oncologica Azienda Ospedaliera Universitaria Senese Siena 53100 Italy Details
NKI Amsterdam 1066 CX Netherlands Details
Radboudumc Nijmegen HP 452 Netherlands Details
Hospital Universitari Vall d'Hebron Barcelona 8035 Spain Details
Institut Catala d'Oncologia Barcelona 8908 Spain Details
START Madrid-HM CIOCC Madrid 28050 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field